Global Safety Prefilled Syringe System Market growing at a CAGR of 11.2% from 2023 to 2030
Category : Pharmaceuticals And Healthcare | Published Date : Aug 2023
Key Market Overview
Consegic Business Intelligence analyzes that the safety prefilled syringe system market is predicted to grow at a compound annual growth rate of 11.2% from 2023 to 2030 and is expected to reach USD 15,173.58 million in 2030 which was valued at USD 6,531.84 million in 2022.
The report highlights the increasing adoption of safety prefilled syringe systems in diabetes treatment, which is augmenting the global market growth. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the safety prefilled syringe system market.
Global Safety Prefilled Syringe System Market By Overview
The safety prefilled syringe system market is bifurcated into product type and application. Based on product type, the market is segmented into disposable prefilled syringes and reusable prefilled syringes. In 2022, the disposable prefilled syringes segment dominate in the overall safety prefilled syringe system market. The application segment is categorized into anaphylaxis, rheumatoid arthritis, diabetes, and others. In 2022, the diabetes segment accounted for the highest market share in the safety prefilled syringe system market.
Get Free SampleMarket Dynamics
Driver:
- The rising prevalence of diabetes is accelerating the demand for safety prefilled syringe systems, thereby fueling market growth at the global level.
- Increasing cases of rheumatoid arthritis are boosting the adoption of safety prefilled syringe systems, which, in turn, is propelling the growth of the global market.
Restraints:
- Compliance with stringent regulations for the manufacturing of safety prefilled syringe systems is restraining the market growth.
Market Segmentation:
| Report Attributes | Report Details |
| By Product Type | Disposable Prefilled Syringes and Reusable Prefilled Syringes |
| By Application | Anaphylaxis, Rheumatoid Arthritis, Diabetes, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Competitive Landscape :
The market is dominated by certain major companies such as BD, Gerresheimer, Nipro Corporation, and Schott which have a strong market position in the current market circumstances. These companies are continuously leveraging new technologies to develop innovative solutions. Furthermore, the safety prefilled syringe system market is expected to witness substantial growth in the coming years due to the increasing development of new healthcare facilities in key regions such as North America, Asia Pacific, and others.
The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships.
- BD
- Gerresheimer
- Nipro Corporation
- Schott
- Stevanato
- Baxter BioPharma Solution
- Rovi CM
- Terumo
- Catalent
- Taisei Kako